Discover
The American College of Artificial Intelligence and Medicine

The American College of Artificial Intelligence and Medicine
Author: Melvin Speisman
Subscribed: 2Played: 17Subscribe
Share
Description
The mission of Doctors Melvin Speisman MD, FACP and Ann Slasuratis FACP is to educate and mentor current and next generation physicians on the intersections of artificial intelligence and medicine via research, teaching, hands on patient care, leadership, scholarships, and volunteerism by way of the American College of Artificial Intelligence and Medicine, their own 501c3 organization. This podcast hopes to spread awareness and educate others as to how the wonders of modern technology are shaping the future of health care forever.
18 Episodes
Reverse
Dr. Mel Speisman specializes in Academic Internal Medicine. He is an expert in the diagnosis and treatment of hypertension, diabetes, congestive heart failure, atrial fibrillation, coronary artery disease, stroke, and other chronic medical conditions. He is interested in the primary prevention of disease with a passion for medical education and bedside teaching. He has received numerous awards from medical students and residents during his 25 year career as a core faculty member of an internal medicine residency program. Dr. Speisman has mentored many physicians to take on leadership roles in academic internal medicine. Mel is a lifetime member of Alpha Omega Alpha Honor Medical Society signifying his lifelong commitment to outstanding patient care, professionalism, leadership, scholarship, research, teaching, and community service. In 2024, Mel completed certification programs in Artificial Intelligence and Healthcare at both Harvard Medical School and Massachusetts Institute of Technology as well as a certification in Artificial Intelligence from Northwestern University Kellogg School of Management. Mel is currently enrolled in the Stanford Artificial Intelligence in Health care Certificate Program with the goal of becoming a world leader at the intersection of AI and Medicine. Mel is a Fellow of the American College of Physicians (FACP) and a Fellow of Artificial Intelligence and Medicine (FAIM). In August 2024, he transitioned from being an Assistant Professor in the Division of Academic Internal Medicine at the University Illinois at Chicago College of Medicine to taking a position as President of the American College of Artificial Intelligence and Medicine.Dr. Ann Slasuraitis has been an Academic Internal Medicine hospitalist and core faculty member of an Internal Medicine residency program for over 20 years. During this time, she was involved with undergraduate, graduate, and continuing medical education as the Director for Continuing Medical Education (CME). She has mentored hundreds of medical students and internal medicine residents and has received numerous teaching awards. Currently, she provides primary care to adults with autism at the Ann Kiley Developmental Center and is the Medical Director of the Rimland Center for Autism Research. Dr. Slasuraitis is a Fellow of the American College of Physicians (FACP) and a Fellow of Artificial Intelligence and Medicine (FAIM). In 2023, Ann received the ACP Illinois Outstanding Women Physician Award. In August 2024, she accepted a position as the Executive Vice President of the American College of Artificial Intelligence and Medicine. Dr. Slasuraitis is committed to life-long learning and in our ever-changing medical profession, she is passionate about educating the current and next generation physicians about artificial intelligence and medicine. Dr. Slasuraitis is currently enrolled in the Stanford Artificial Intelligence in Health care Certificate Program.www.AmericanCollegeAim.org
Dr. Leeda Rashid, MD, MPH, is a current Hospitalist with Almeda Health System in California and former Senior physician at the FDA’s Digital Health Center of Excellence within the Center for Devices and Radiological Health. With a career spanning clinical care, AI-driven healthcare innovation, and global health advocacy, she has worked with startups to develop digital health and clinical decision support tools, advised international agencies delivering health tech solutions to underserved populations, and continues to practice as a hospitalist serving marginalized communities. A graduate of Oregon Health & Science University and the Harvard School of Public Health, Dr. Rashid brings a systems-level view of healthcare and a passion for using digital health to improve access and quality for all patients.www.Americancollegeaim.org
Hooman H. Rashidi MD, MS, FCAPAssociate Dean of AI in Medicine, Professor & Endowed Chair of Lombardi-Shinozuka Experimental Pathology Research at University of Pittsburgh School of Medicine, Executive Vice Chair of Computational Pathology & Informatics Division at UPMC, Executive Director of CPACE (Computational Pathology & AI Center of Excellence)Dr. Rashidi combines his passion for patient care, research and education with his unique training in bioinformatics and machine learning (ML) to create innovative new tools (i.e. MILO, STNG, Pitt-GPT+, WSI-Genie, Nebulon-GPT, etc.) and resources (Hematology Outlines, Cleveland Clinic's AI course, etc.) that improve clinical practice, research and education.His experience in AI/ML dates back to his graduate years at UCSD which subsequently allowed him to serve as the principal author and editor of several popular bioinformatics textbooks. This background has also enabled him to develop various novel AI-ML platforms. He is currently the Associate Dean of AI in Medicine, Professor & Endowed Chair of Lombardi-Shinozuka Experimental Pathology Research at the University of Pittsburgh School of Medicine, Executive Director of CPACE (Computational Pathology & AI Center of Excellence) and the Executive Vice Chair of the Computational Pathology & Informatics Division at UPMC. He is also Adjunct Professor of Engineering at the Carnegie Mellon University. Before joining University Pittsburgh / UPMC, he served as the founding director of Cleveland Clinic’s Center for Diagnostics & Artificial Intelligence & Vice Chair of Technology Innovation & Computational Pathology, and before that he served as the Director of AI for University of California Davis Medical Center and Professor & Vice chair of informatics, leading a large number of AI studies with numerous collaborators from various prominent institutions. These experiences and studies have also led to the invention of numerous products (most recent of which being the on-prem LLM framework Pitt-GPT+, the automated Image analytics frameworks WSI Genie and Auto-Pix AI) & several filed patents/established products (e.g. the University of California IP MILO: Machine Intelligence Learning Optimizer, the proprietary Automated ML platform & it’s suite of 6 complimentary separate unique Data Science and Statistics Apps & Cleveland Clinic’s new automated synthetic data generator and Validation platform STNG, Synthetic Tabular Neural Generator) along with a large number of manuscripts in which he serves as corresponding author. These products have also been licensed to several industry and academic institutions & serving as a powerful suite of data science tools for a large number of clinical, quality, research and educational projects while also starting to help optimize and expedite data access needs for all investigators.In addition to the above, Dr. Rashidi is also a practicing physician (board certified hematopathologist) and a well-known educator with numerous teaching awards who has created some of the AppStore’s most popular hematology Apps along with Cleveland Clinic’s most recent AI-ML course (launched Cleveland Clinic wide in Jan 2024). He is also the co-founder and senior editor of HematologyOutlines, a very popular digital hematology atlas that is used internationally and endorsed by the American Society of Clinical Pathology.
Christopher Whelchel, MHAChristopher Whelchel is a seasoned healthcare strategist, health tech researcher, and AI thought leader with over 20 years of experience transforming clinical operations and advancing innovation in medical systems. He currently serves as the CEO and Founder of HealthTok, where he focuses on leveraging artificial intelligence to enhance healthcare efficiency and outcomes.A doctoral candidate, Christopher is deeply immersed in researching AI applications that streamline workflows and drive operational excellence across the healthcare spectrum. With a robust background in change management, data mining, and clinical process automation, he brings a methodical yet visionary approach to solving today’s most complex healthcare challenges.In addition to his executive leadership, Christopher is a compelling speaker and educator, frequently sharing insights on the intersection of emerging technologies and modern medicine. His passion lies in bridging the gap between advanced data-driven solutions and practical, evidence-based healthcare delivery.www.americancollegeaim.org
Justin Ramsaran is 30 Under 30 Nominee and an American digital health developer and entrepreneur who leverages cross-functional business strategies and digital transformation with artificial intelligence to empower individuals and advance healthcare systems. He is the CEO of R Group, a digital healthcare innovation company focused on developing next-generation clinical data systems to support future healthcare providers. Additionally, he serves as the VP of Digital Health Solutions for Fukuda Denshi, a Japanese medical device manufacturer dedicated to "transforming world-class technology into accessible healthcare for everyone."Justin is currently a doctoral candidate at Florida Tech, working on his dissertation at NYU Stern. At Florida Tech, he began developing the concept of integrating cross-functional business organization strategies from fintech, big tech, and Al companies into the healthcare system through an"Open Connected Architecture." In parallel, Justin continues to apply these cross-functional business strategies to other industries, including higher education and sports technology.Manifesto:Augment Human Learning with Machine Learning: Especially for social good.Utilize Unconventional Approaches to Complex Problems: Develop simple solutions.While these two ideas may seem disparate, they are interdependent. Humans often hold false notions about the world and encountermisinformation, yet we excel in learning within noisy environments. Augmenting human learning with machine learning requires a deeper understanding of learning in such environments. Across healthcare,agriculture, politics, economics, and transportation, our future as a species relies on the increasing synergy between machine learning and human learning. It is paramount that we develop tools to handle real-world uncertainty while ensuring our advancements in machine intelligence are directed towards social good.www.AmericancollegeAim.org
Dr. Mel Speisman interviews Ramprabananth a Radiologist from Norway about AI.A practicing AI Radiologist, Prabhu will discuss the rapid advancements in Artificial Intelligence (AI), leading to a significant transformation in the work patterns of Radiologists and explain how he has integrated AI into the radiology department at Baerum Hospital in Norway, where approximately 40% of his work is focused on AI-related tasks including working in the integration of AI tools across the hospital chain to enhance workflow, diagnostic accuracy and efficiency. https://www.linkedin.com/in/ramprabananth/overlay/about-this-profile/?lipi=urn%3Ali%3Apage%3Ad_flagship3_profile_view_base%3BhFChbj7IQbGKXIt%2FSKSoVg%3D%3D
Doctors Melvin Speisman and Andrea Slasuraitis have a discussion with Doctors Deepti Pandita and Amit Kumar Dey.Dr. Deepti Pandita is the Chief Medical Information Officer and VP of Clinical Informatics University of California Irvine. Dr. Pandita is Board Certified in Internal Medicine and in Clinical Informatics. She is currently Associate Professor of Medicine at UCl and Faculty for the Cl Fellowship program at UCl. She was previously CHIO and Program Director of the Clinical Informatics Fellowship at Hennepin Healthcare in Minneapolis, MN. She received her Medical Degree from Christian Medical College, Vellore, India and did her residency training at University of North Dakota. Dr. Pandita is a Board member of the American Medical Informatics Association and Chair of the Medical Informatics Committee for the American college of Physicians leading several National committees and initiatives.Deepti has a passion for using innovation and technology to improve care delivery for the underserved and marginalized populations and participates in health disparities research more specifically on bridging digital disparities. Her passion and research are to continue working to create health equity in the space of Telemedicine for all underserved populations beyond the Pandemic. Deepti is also engaged in digital Innovation and seeking novel solutions to ease cognitive burden of Clinical teams and promote wellness.Dr. Amit Kumar DeyPhysician | Diabetologist | Metabolic Medicine I Obesity Care | Doctorpreneur | Digital Therapeutics I Artificial Intelligence | DoctorsAlDr. Amit Kumar Dey is a distinguished Consultant Physician specializing in Diabetology, Obesity, and Metabolic Disorders with over 12 years of clinical experience. Based in Kolkata, India, he has been recognized for his contributions to diabetes care and technology innovation, receiving multiple awards including the Diabetes Awareness Initiative Award at Diabetes India 2020, the JPEF2023 Award, and the American College of Physicians (ACP) India Chapter Governors Recognition Award in 2024 for his work in Artificial Intelligence in Healthcare. Certified by the American Board of Artificial Intelligence in Medicine (ABAIM), he is a Fellow of the Royal Society of Public Health (UK) and Diabetes India (DI), and a key advisory member of the ACP India Chapter.Dr. Dey is the Founder Chair of Doctors Al, a medical community connecting over 2000 healthcare professionals on Al-related topics. He serves as an associate editor at JMIR Diabetes, and as a faculty member at the National Diabetes Education Program (NDEP). He has published extensively in peer-reviewed journals, contributed to book chapters, and presented at numerous national and international conferences. His research interests include diabetes management in the elderly, continuous glucose monitoring (CGM) in gestational diabetes, and the application of Al in precision diabetes care. He is also the host of the widely acclaimed podcast series "MedAl - Decoding Al in Healthcare," which has reached a global audience in over 60 countries.If you'd like to learn more about using Ai for Good please visit our website at Www.americancollegeaim.org
Doctors Mel Speisman and Connor Yost discuss how artificial intelligence is being utilized in current medical education by educators and students. As well as how Ai is currently helping doctors rediscover their love for helping patients and also theorize how it may soon assist physicians in fields such as Oncology where it is, at least at the current time, seemingly still vastly under utilized. Connor is currently a Resident at Creighton University School of Medicine in Phoenix, Arizona and a relatively new member here at The American College of Ai and Medicine but we are extremely grateful for all of his insights and taking the time out of his busy schedule to spend time with us on today's podcast. If you are interested in joining us at our first ever Scientific Session on September 19-20, 2025 at McCormick Place Convention Center in Chicago, IL you can sign up to attend or volunteer at our website.Www.AmericanCollegeAIM.Org
Dr. Mel Speisman interviews Dr. Abhineet Kumar MD Lead Hospitalist at Banner Health in Phoenix Arizona. In this episode we learn how Dr. Kumar became one of the first physicians to deploy AI in hospital medicine and gain insights into the ability of AI to be a difference maker in both patient safety and quality improvement in caring for patients in the inpatient setting.Www.AmericanCollegeAIM.org
Dr. Kottler is the Associate Chief Medical Officer for Clinical Artificial Intelligence at Radiology Partners, the largest radiology practice in the USA and associate fellow at the Center for Artificial Intelligence and Medicine and Imaging at Stanford University. Nina will be giving a keynote address at the Scientific Session of the American College of Artificial Intelligence and Medicine September 20 at McCormick Place in Chicago. If you’d like to attend the two day conference on September 19th and 20th, 2025 at McCormick Place Convention Center in Chicago, Illinois, sign up at our website Www.americancollegeaim.org. We look forward to seeing you all there.
Today, we invite you all to an interview with Vishisht Mehta MD Assistant Professor at the University of Nevada, Las Vegas and Chairman of Pulmonary and Interventional Pulmonolgoist at Mountainview Hospital in Las Vegas, Nevada. Having completed his pulmonary critical care fellowship at Memorial Sloan Kettering Cancer Center, Dr. Mehta is an expert in using AI for screening, diagnosis, and staging of lung nodules and lung cancers.If you like what you heard here today, feel free to join us at Www.AmericanCollegeAIM.org and sign up for fellowship and/or to attend our first ever conference at McCormick Place Convention Center in Chicago, IL September 19th and 20th, 2025
In this lecture given to the Internal Medicine Residency program at Saint Francis Hospital, Dr. Melvin Speisman discusses how Ai is already aiding and revolutionizing the Gastroenterology field. From increased efficiency and accuracy of diagnosis to using wearable smart watches in order to aid IBD patients, Artificial Intelligence is really becoming a major game changer in the medical field despite it only really being in it's infancy. With more and more hospitals implementing this technology and even more impressive large language models being developed, there's truly no end to how beneficial this technology will be to both patients and physicians alike.Sign up to join us and also attend our first ever Scientific Session at McCormick Place Convention Center in Chicago, Illinois on September 19th and 20th, 2025. You must sign up to attend. We can't wait to see you all in person here in Chicago. Go to Www.AmericanCollegeaim.org for more info.
Dr. Matilda Dorotic is an Associate Professor in the Department of Marketing at BI Norwegian Business School in Oslo, Norway. Originally from Croatia, she has built an impressive academic career focusing on the intersection of social behavioral science and emerging technologies, particularly artificial intelligence (AI).Dr. Dorotic’s research employs experimental methods, trade-off analysis, and data analytics to explore the impact of emerging technologies on citizens, societal well-being, and public policy. She places a strong emphasis on critical AI safeguards, including transparency, explainability, human oversight, privacy, and compliance with human rights.In addition to her role at BI Norwegian Business School, Dr. Dorotic is a research affiliate at the Massachusetts Institute of Technology (MIT) in the United States. Her work at MIT further explores the effects of emerging technologies on society and public policy, with a particular focus on AI regulation.Professor Melvin Speisman and Professor Dorotic discuss the importance and inevitable future of governance in AI.Join us at our website at AmericanCollegeAiM.orgAlso sign up to attend our first ever Live Scientific Session At McCormick Place Convention Center in Chicago, IL USA September 19 and 20, 2025
In this Episode, Professor Melvin Speisman delivers an insightful lecture to Insight Hospital and Medical Center in Chicago, IL on how the use of Artificial Intelligence is currently aiding and revolutionizing Pulmonary and Critical Care Medicine today and why it's inevitable for daily use going forward to save millions of patients' lives. If you enjoyed what you heard in today's episode and want to learn more about the emergence and utilization of AI in Medicine consider joining as at www.americancollegeaim.org and become a member. Also SAVE THE DATE: September 19th and 20th at McCormick Place Convention Center in Chicago, IL for our first ever Scientific Session and convention. Visit our website to register to attend today.
In this episode, Dr. Melvin Speisman explores the transformative impact of artificial intelligence in cardiology. From diagnostic advancements to predictive analytics and personalized treatment plans, Dr. Speisman dives into how AI is reshaping patient care and outcomes in cardiovascular medicine. This insightful lecture sheds light on both the current applications and future potential of AI, offering a glimpse into the evolving landscape of cardiology in the age of technology.Check out the website of American College of AI and Medicine and join us! https://americancollegeaim.org/
Doctors Melvin Speisman and Ann Slasuraitis host special guest Dr. June Lau, Chairperson of Ai in Healthcare and Digital Health Committee, as they all take a deep dive into the past, present, and future of Artificial Intelligence in Medicine. How it's currently being implemented, how Ai is being adopted globally. As well as their hopes and insights into its very near future. Doctor June has brought her vast expertise and experience all the way from Kuala Lumpur, Malaysia to the Chicago area where she now currently resides.Malaysian Medical Association- https://mma.org.my/The American College of Ai and Medicine- https://americancollegeaim.org
A casual conversation about the American College of Ai and Medicine and Dr. Melvin Speisman personally. How the college came about and its mission. After this brief intro and explanation we jump right into Dr. Speisman's insightful lecture from 11/08/2024 at the University of Illinois College of Medicine in Rockford, Illinois on the Intersection of Artificial Intelligence and Medicine.
In a casual conversation with Dr. Melvin Speisman, he explains exactly how Ai is currently being utilized in today's medical world and how it's already beneficially shaping the future. Artificial Intelligence is taking over Health Care in a big way and this is only the beginning. Join us as we dive into this groundbreaking new world.